 Product Service News
September 22, 2025
Durango, Colorado In an exciting development for chocolate lovers and franchisees alike, Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) proudly announces the opening of two new store locations at Palladio Mall in Folsom, California, and at the Jersey Shore Premium Outlets in Tinton Falls, New Jersey. With t...
|
Business Update
September 22, 2025
In a landmark achievement, Tempus AI, Inc. (NASDAQ: TEM) has secured a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its novel RNA-based Tempus xR IVD device. This development holds significant implications not only for the company but also for the broader landscape of precision medicine and ...
|
Clinical Study
September 22, 2025
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, significantly affecting the lives of millions of Americans. Smoking is the primary risk factor for developing COPD, yet many patients struggle to quit. Innovative therapeutic interventions are crucial to support this vulnerab...
|
|
 Product Service News
September 22, 2025
In a promising development for the field of gene-based therapies, CRISPR Therapeutics and Sirius Therapeutics have announced the initiation of a Phase 2 clinical trial for SRSD107, marking the dosing of the first patient. This collaboration highlights the growing trend of utilizing cutting-edge genetic technologies ...
 Announcement
September 22, 2025
Ferrari N.V., renowned for its luxury automobiles and iconic racing pedigree, recently announced significant strategic updates that point towards a robust trajectory for the company as it gears up for the future. On September 22, 2025, Ferrari released its periodic report detailing the eighth tranche of its ongoing ...
|
|
Our most Popular Articles
|
Product Service News
September 24, 2025
for CSIMarket.com BlackRock Canada Continues to Deliver with Final September Cash Distributions Amid a Tumultuous Market In the volatile seas of the financial markets, where stock charts resemble jagged peaks and troughs more akin to a rollercoaster than steady progress, BlackRock Canada demonstrates that even s...
|
Business Update
September 30, 2024
On a bright Thursday morning in Mountain View, California, Intuit Inc. the global financial technology powerhouse known for its widely-used products, such as TurboTax, QuickBooks, and Credit Karma, gathered investors and analysts for its annual Investor Day. The event served as a platform to reaffirm the company’s...
|
Announcement
June 20, 2025
Abstract: Enlivex Therapeutics Ltd. has reported compelling interim results from its Phase I clinical trial of Allocetra, an innovative macrophage reprogramming immunotherapy. This article examines the data from the study, which focuses on the treatment of moderate to severe knee osteoarthritis and highlights the ...
|
|
|
Company News
|
Business Update
September 22, 2025
In a landmark achievement, Tempus AI, Inc. (NASDAQ: TEM) has secured a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its novel RNA-based Tempus xR IVD device. This development holds significant implications not only for the company but also for the broader landscape of precision medicine and ...
|
Clinical Study
September 22, 2025
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, significantly affecting the lives of millions of Americans. Smoking is the primary risk factor for developing COPD, yet many patients struggle to quit. Innovative therapeutic interventions are crucial to support this vulnerab...
|
Product Service News
September 22, 2025
In a noteworthy juxtaposition, LGI Homes recently celebrated the grand opening of Estrella at High Range in Rio Rancho, New Mexico, marking its highly anticipated return to the area. This homebuilder s revitalization effort casts a spotlight on a broader narrative of struggle within the company, particularly when co...
|
|
|
Company News
 Product Service News
September 22, 2025
|
Company News
 Product Service News
September 22, 2025
|
Company News
Clinical Study
September 22, 2025
|
More Company News
|
Clinical Study
September 22, 2025
|
Announcement
September 22, 2025
|
Announcement
September 22, 2025
|
Clinical Study
September 22, 2025
|
Clinical Study
September 22, 2025
|
Business Update
September 22, 2025
|
Product Service News
September 22, 2025
|
Business Update
September 22, 2025
|
Announcement
September 22, 2025
|
Product Service News
September 22, 2025
|
|
|
|
Related News
|
Business Update
|
Partnership
|
|
Stocks
|
Product Service News
|
Partnership
|
Business Update
|
|
|
|
Business News
|
|
Product Service News
In a promising development for the field of gene-based therapies, CRISPR Therapeutics and Sirius Therapeutics have announced the initiation of a Phase 2 clinical trial for SRSD107, marking the dosing of the first patient. This collaboration highlights the growing trend of utilizing cutting-edge genetic technologies ...
|
|
Announcement
Ferrari N.V., renowned for its luxury automobiles and iconic racing pedigree, recently announced significant strategic updates that point towards a robust trajectory for the company as it gears up for the future. On September 22, 2025, Ferrari released its periodic report detailing the eighth tranche of its ongoing ...
|
 Announcement
KinderCare Legal Troubles: A World of Opportunity or Alarm for Investors In a striking development that may pique the interest of shareholders and market analysts alike, a notable securities class action lawsuit has been launched against KinderCare Learning Companies, Inc. (NYSE: KLC). Spearheaded by the prominent ...
|
 Product Service News
In an era where data-driven insights are paramount, Triumph has taken significant strides in enhancing the capabilities of brokers through the launch of an integrated Intelligence solution. This new offering combines critical aspects of pricing, performance, and capacity data into a unified platform, designed to emp...
|
 Product Service News
Durango, Colorado In an exciting development for chocolate lovers and franchisees alike, Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) proudly announces the opening of two new store locations at Palladio Mall in Folsom, California, and at the Jersey Shore Premium Outlets in Tinton Falls, New Jersey. With t...
|
Our Most Popular Articles
|
 Product Service News
for CSIMarket.com BlackRock Canada Continues to Deliver with Final September Cash Distributions Amid a Tumultuous Market In the volatile seas of the financial markets, where stock charts resemble jagged peaks and troughs more akin to a rollercoaster than steady progress, BlackRock Canada demonstrates that even s...
|
 Business Update
On a bright Thursday morning in Mountain View, California, Intuit Inc. the global financial technology powerhouse known for its widely-used products, such as TurboTax, QuickBooks, and Credit Karma, gathered investors and analysts for its annual Investor Day. The event served as a platform to reaffirm the company’s...
|
 Announcement
Abstract: Enlivex Therapeutics Ltd. has reported compelling interim results from its Phase I clinical trial of Allocetra, an innovative macrophage reprogramming immunotherapy. This article examines the data from the study, which focuses on the treatment of moderate to severe knee osteoarthritis and highlights the ...
|
More News
|
 Business Update
In a landmark achievement, Tempus AI, Inc. (NASDAQ: TEM) has secured a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its novel RNA-based Tempus xR IVD device. This development holds significant implications not only for the company but also for the broader landscape of precision medicine and ...
|
 Clinical Study
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, significantly affecting the lives of millions of Americans. Smoking is the primary risk factor for developing COPD, yet many patients struggle to quit. Innovative therapeutic interventions are crucial to support this vulnerab...
|
 Product Service News
In a noteworthy juxtaposition, LGI Homes recently celebrated the grand opening of Estrella at High Range in Rio Rancho, New Mexico, marking its highly anticipated return to the area. This homebuilder s revitalization effort casts a spotlight on a broader narrative of struggle within the company, particularly when co...
|
 Product Service News
In a world where the hustle and bustle of modern life can often lead to increased stress and sleep-related issues, innovative solutions are continuously emerging to enhance well-being. One such solution has recently received notable acclaim. On September 22, 2025, electroCore, Inc. (Nasdaq: ECOR), a pioneering compa...
|
 Product Service News
Cosmos Health Ventures into U.S. Nutraceuticals Market with Sky Premium Life Brand, Anticipates Robust Financial Growth London, UK - Cosmos Health, a burgeoning player in the global health and wellness industry, has officially commenced its operations in the United States, targeting the lucrative $164 billion nutrac...
|
 Clinical Study
In an important development for ocular gene therapy, Adverum Biotechnologies, Inc. (Nasdaq: ADVM) has announced the imminent completion of patient screening for its pivotal Phase 3 ARTEMIS trial evaluating Ixo-vec, a groundbreaking therapy for wet age-related macular degeneration (wet AMD). This announcement, made o...
|
|
Clinical Study
Vitiligo, an autoimmune skin disorder characterized by the loss of pigment, poses significant therapeutic challenges. Recent advancements have highlighted the potential for combination therapies to enhance treatment efficacy and safety for patients. A pivotal study, published in the International Journal of Dermato...
|
 Announcement
Allarity Therapeutics, Inc. is making significant strides in the realm of oncology, particularly with its promising drug candidate, stenoparib, in the treatment of platinum-resistant ovarian cancer. Recent clinical data presented by the company highlights an important milestone: the median overall survival (OS) for ...
|
 Announcement
The New York Film Festival (NYFF), one of the prestigious events in the cinematic calendar, has officially announced Getty Images as its Official Photographer for the 63rd edition of the festival. This partnership aims to enhance the visual narrative surrounding the event, showcasing the diverse array of films, film...
|
 Clinical Study
Intellia Therapeutics Inc. is set to present compelling longer-term data from its ongoing Phase 1 clinical trial of Nexiguran Ziclumeran (nex-z), an innovative therapeutic approach for treating hereditary transthyretin (ATTR) amyloidosis with polyneuropathy (ATTRv-PN). This significant update will be unveiled at the...
|
 Clinical Study
In the ever-evolving landscape of biopharmaceuticals targeting genetic diseases, BridgeBio Pharma, Inc. stands out as a company committed to advancing treatment options for conditions associated with transthyretin (TTR) amyloidosis, specifically transthyretin amyloid cardiomyopathy (ATTR-CM). With the impending 202...
|
 Business Update
Brewing Entertainment: The Unprecedented Global Partnership Between AB InBev and Netflix In a groundbreaking move that merges the realms of brewing and streaming, AB InBev and Netflix have announced a global brand partnership unlike any other. This collaboration promises to intertwine the world s most iconic beer br...
|
 Product Service News
Gogo s Strategic Leap: EASA Certification for Galileo HDX Antenna Signals Growth PotentialGogo Inc. (NASDAQ: GOGO), a prominent player in the aviation connectivity sector, has made significant strides in establishing its foothold in Europe. On September 22, 2025, the company announced that QCM Design, a Switzerland-based firm, has received the coveted European Union Aviation Safety Agency (EASA) approval for its Supplemental Type Certificate (STC), specifically for the Gogo Galileo HDX antenna. This critical certification facilitates the retrofit installation of the state-of-the-art antenna on Bombardier’s Global 5000 and Global 6000 series aircraft, marking a pivotal moment for both Gogo and the European aviation market.The EASA STC certification is not merely a regulatory milestone; it represents Gogo s commitment to enhancing in-flight connectivity for a niche yet lucrative segment of the business aviation market. The Galileo HDX antenna distinguishes itself through its advanced capabilities, promising superior connectivity and bandwidth for aircraft operating across European airspace and beyond. By aligning its technology with the needs of Bombardier Global aircraft, Gogo is strategically positioning itself to capture the burgeoning demand for high-speed internet access in business aviation.
|
 Business Update
In an unexpected twist that highlights the shifting dynamics of the retail landscape, The ODP Corporation (NASDAQ: ODP), a stalwart in providing innovative products, services, and technology solutions, announced today its definitive agreement to be acquired by an affiliate of Atlas Holdings in a robust all-cash tran...
|
 Announcement
In a significant development within the semiconductor and quantum technology landscape, SEALSQ Corp, a forward-thinking leader in semiconductor technology, announced on September 22, 2025, a Memorandum of Understanding (MoU) with the Seoul Metropolitan Government and Invest Seoul. This strategic partnership aims to ...
|
 Product Service News
In an era where the online marketplace is as competitive as ever, the ability to efficiently manage e-commerce operations has never been more vital. Enter Crystal Art Gallery, a California-based powerhouse known for its stunning art and home décor products. With a growing demand for seamless shopping experiences, C...
|
|
|
|
|
